Bangalore-based biotech startup Mestastop has raised an undisclosed amount from Mumbai Angels Network.
Founded by Arnab Roy Chowdhury, Mestastop is a biotech startup that aims to stop ‘Cancer Metastasis’ through its smart sciences technology.
Speaking on the investment in Mestastop, Mumbai Angel member, Satyakam Mohanty said, “Discovery is as much key to treating metastatic cancer as is the cure, if not more. The nature of metastatic tumors is such that cure becomes exponentially harder (and more expensive), the latter the discovery. Using unique cell-based detection IP techniques, Mestastop is charting a pioneering and much-needed path to early detection of metastasis. Such work is key to furthering mankind’s understanding of human health.”
Commenting on the fundraise, Dr. Arnab Roy Chowdhury, Founder of Mestastop said, “Mestastop is trying to solve a highly complex global healthcare problem and an investment from Mumbai Angels is not only a validation of our vision and progress but also a shot of adrenaline during the pandemic crisis, priming us for the next level.”
Adding to the statement, Nandini Mansinghka, Co-promoter & CEO of Mumbai Angels Network said, “Mestastop aims to create a common metastasis-directed proprietary platform that will address both discovery and diagnostic goals. We are excited to see how Mestastop will create solutions for cancer care. We see our new LifeSciences vertical growing and we are happy to see more companies from this sector becoming part of our expanding portfolio.”
